End of the road: confounding results of the CORE trial terminate the arduous journey of cilengitide for glioblastoma
This is sadly the end of the drug Cilengitide. We all had high hopes for it. They tried many different combinations and all of the trials failed, so they are giving up on it. It is sad because it seemed to make a lot of sense, which we thought would translate into a benefit but it didn't work out.
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://neuro-oncology.oxfordjournals.org/content/early/2015/02/13/neuonc.nov018.extract
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines